Supplementary analyses extended these findings to gastrointestinal tumors, where DVL1 was linked to poor prognosis and altered immune landscapes, reinforcing its role as a critical gene across multiple conditions (Supplementary Figure 1). Here, DVL1 is linked to digestive system neoplasm.